StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Skrit37on Mar 11, 2020 12:07pm

137 Views

Post# 30793607

RE:RE:RE:RE:RE:RE:RE:Dog

The reason why we are at .035 isnt because money is flowing in,or because targets continually get hit, or we can hinge on managements word, or garenteed revenue agreements have been signed...again we are were we are because non of the above exist as of yet.....or very little If your invested ...have patience in the conpanys potential...this stock cant get much cheaper..unless any of the above become factual.. we will stay were we are... On the bright side, you keep accumulating shares for dirt cheap untill then

Bullboard Posts

Debt-free cannabis company set for next stage of growth